4-desacetylvinblastine-3-carboxhydrazide has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, AL; Briggs, SL; Bumol, TF; Corvalan, JR; Cullinan, GJ; Johnson, DA; Laguzza, BC; Nichols, CL; Starling, JJ | 1 |
| Bumol, TF; Johnson, IS; Spearman, ME; Todd, GC; Zimmerman, JL | 1 |
2 other study(ies) available for 4-desacetylvinblastine-3-carboxhydrazide and Experimental Neoplasms
| Article | Year |
|---|---|
New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity.
Topics: Animals; Antibodies, Monoclonal; Drug Design; Humans; Immunotoxins; Mice; Mice, Nude; Neoplasms, Experimental; Structure-Activity Relationship; Vinblastine | 1989 |
Monoclonal antibody drug conjugates for site-directed cancer chemotherapy: preclinical pharmacology and toxicology studies.
Topics: Animals; Antibodies, Monoclonal; Immunotoxins; Mice; Neoplasms, Experimental; Rats; Vinblastine | 1987 |